BPIFA2 anticorps (AA 151-249)
Aperçu rapide pour BPIFA2 anticorps (AA 151-249) (ABIN2171168)
Antigène
Voir toutes BPIFA2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 151-249
-
Homologie
- Human
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human C20orf70
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- BPIFA2 (BPI Fold Containing Family A, Member 2 (BPIFA2))
-
Autre désignation
- C20orf70
-
Sujet
-
Synonyms: bA49G10.1, chromosome 20 open reading frame 70, lung and nasal epithelium carcinoma-associated protein 2, Neonatal submandibular gland protein, Parotid secretory protein, PSP, Short palate, short palate lung and nasal epithelium carcinoma associated 2, short palate, lung and nasal epithelium carcinoma associated protein 2, SPLC2_HUMAN, SPLUNC2.
Background: C20orf70
Antigène
-